Chromium picolinate side effects
Pro Research Analysisby 
Searched over 200M research papers
Chromium Picolinate Side Effects
Introduction to Chromium Picolinate
Chromium picolinate is a popular dietary supplement often marketed for weight loss, muscle mass increase, and improved lipid profiles. It is a synthetic compound that provides a bioavailable form of chromium (Cr(III)), which is better absorbed than dietary chromium . Despite its popularity, there are concerns about its potential side effects and safety.
Mutagenicity and Cellular Toxicity
Research has shown that chromium picolinate can induce mutagenic responses in certain cell types. Specifically, studies using L5178Y mouse lymphoma cells demonstrated that chromium picolinate induced mutagenic responses both with and without the addition of S9, a liver enzyme mix used to simulate metabolism . This suggests potential cellular toxicity and raises concerns about its long-term safety.
Renal and Glycemic Effects
High doses of chromium picolinate have been studied for their effects on renal function and glycemic control. In diabetic db/db mice, high doses of chromium picolinate mildly improved glycemic status and reduced albuminuria, a marker of kidney damage, without increasing DNA damage . However, the long-term implications of these findings for human health remain unclear.
Impact on Lipid Profiles and Inflammatory Markers
Chromium picolinate has been shown to have beneficial effects on lipid profiles and inflammatory markers in patients with non-alcoholic fatty liver disease (NAFLD). Supplementation significantly reduced triglycerides, very-low-density lipoprotein (VLDL), insulin levels, and several inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP) and tumor necrosis factor-alpha (TNF-α) . These findings suggest potential benefits for metabolic health, although the long-term safety profile needs further investigation.
Effects on Body Composition and Strength
Despite claims of benefits for body composition and strength, studies have shown mixed results. In football players, chromium picolinate supplementation did not result in significant changes in body composition or strength during a period of intensive weight-lifting training . Similarly, in healthy, non-obese older adults, chromium picolinate did not improve insulin sensitivity, serum lipids, or body composition .
Potential for DNA and Oxidative Damage
There is evidence suggesting that chromium picolinate may cause oxidative damage to DNA and lipids. Studies in cell cultures and rats have indicated that chromium picolinate can generate oxidative damage, although the significance of these findings for humans remains uncertain . This potential for oxidative damage warrants caution, especially with long-term use.
Hematologic and Iron Status
Concerns have been raised about the impact of chromium picolinate on iron status, given that chromium competes with iron for binding to transferrin. However, a study in older men found that high-dose chromium picolinate supplementation did not adversely affect hematologic indexes or iron status . This suggests that, at least in the short term, chromium picolinate may not significantly impact iron metabolism.
Conclusion
Chromium picolinate is a widely used supplement with potential benefits for lipid profiles and inflammatory markers. However, its safety profile is not fully understood, with evidence of mutagenic responses, potential oxidative damage, and mixed results on body composition and strength. Further long-term studies are needed to fully elucidate the safety and efficacy of chromium picolinate supplementation.
Sources and full results
Most relevant research papers on this topic
Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells.
Chromium picolinate may induce mutagenic responses in L5178Y mouse lymphoma cells, potentially affecting its effectiveness in weight loss and muscle mass.
DOI
A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
Chromium picolinate supplementation significantly reduces triglyceride levels, insulin resistance, and inflammation in patients with nonalcoholic fatty liver disease without affecting cholesterol levels or liver steatosis intensity.
DOI